Thanks to the folks over at the FDA law blog for tipping us off to interesting provisions of pending legislation that emerged earlier this week from various house committees. The bill, H.R. 5, is part of the ongoing debate over health care, and where it will ultimately go is unclear, but it contains some interesting ideas about punitive damages and it has a raft of sponsors.

There are a variety of provisions governing “health care lawsuits” generally (statute of limitations, caps, contingent fees, periodic payments, etc.), but we’re just going to point out those unique to prescription medical product liability litigation. Those are found in section “c” and mostly deal with punitive damages.